Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer

Publication | Closed Access

DOI

Citations

References

2000

Year

Michael I. Koukourakis, Alexandra Giatromanolaki, S Kalokyris, Vassilis Georgoulias, G. Retalis, N Bahlitzanakis

Medical Oncology

Residual CancerMedicineMetronomic TherapyPharmacologyPharmacotherapyMolecular OncologyCancer TreatmentIncomplete ResponseOncologyRadiation OncologyPhase I/iiCancer ResearchRadiologyHealth Sciences